Drug evaluation: Ranirestat - an aldose reductase inhibitor for the potential treatment of diabetic complications

被引：0
|
作者：
Giannoukakis, Nick [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Inst Diabet, Pittsburgh, PA 15213 USA
来源：
CURRENT OPINION IN INVESTIGATIONAL DRUGS | 2006年 / 7卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Ranirestat is an orally available aldose reductase inhibitor under development by Dainippon Sumitomo Pharma Co Ltd ( formerly Dainippon Pharmaceutical Co Ltd), Kyorin Pharmaceutical Co Ltd and Eisai Co Ltd for the potential treatment of diabetic complications, such as neuropathy, cataracts, retinopathy and nephropathy. Phase III trials were ongoing in February 2006.
引用
收藏
页码：916 / 923
页数：8
相关论文
共 50 条
  • [31] Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications
    Yabe-Nishimura, C
    [J]. PHARMACOLOGICAL REVIEWS, 1998, 50 (01) : 21 - 33
  • [32] CADD Studies in the Discovery of Potential ARI (Aldose Reductase Inhibitors) Agents for the Treatment of Diabetic Complications
    Gupta, Saurabh Kumar
    Tripathi, Pushpendra Kumar
    [J]. CURRENT DIABETES REVIEWS, 2023, 19 (09) : 55 - 63
  • [33] The discovery and development of Lindorestat, a highly potent and selective inhibitor of aldose reductase for treatment of diabetic complications.
    Van Zandt, MC
    Jones, JH
    Geraci, LS
    Gunn, DE
    Jones, ML
    Sawicki, D
    Sredy, J
    Howard, E
    Podjarny, A
    Cannan, S
    Carrington, A
    Sabetta, A
    Jacot, J
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A91 - A91
  • [34] Prevention of diabetic ocular complications in spontaneously diabetic Torii rats by aldose reductase inhibitor fidarestat
    Kakehashi, A
    Saito, Y
    Ono, R
    Sugi, N
    Mori, K
    Kuroki, M
    Kawakami, M
    Kanazawa, Y
    Hirooka, H
    Kato, N
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U92 - U92
  • [35] An aldose reductase inhibitor, fidarestat, prevents diabetic ocular complications in spontaneously diabetic Torii rats
    Kakehashi, Akihiro
    Takezawa, Mikiko
    Toyoda, Fumihiko
    Noshita, Nozomiki
    Mameuda, Chiho
    Yamagami, Hiroko
    Kato, Noriaki Kato Noriaki
    Ishikawa, San-E
    Kawakami, Masanobu
    Kanazawa, Yasunori
    [J]. DIABETES, 2008, 57 : A233 - A233
  • [36] Evaluation of ranirestat for the treatment of diabetic neuropathy
    Giannoukakis, Nick
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (07) : 1051 - 1059
  • [37] A study on aldose reductase and diabetic chronic complications
    Liu, CS
    Zhu, XX
    [J]. ADVANCES OF DIABETES MELLITUS IN EAST ASIA, 1997, 1141 : 211 - 212
  • [38] THE ROLE OF ALDOSE REDUCTASE IN THE DEVELOPMENT OF DIABETIC COMPLICATIONS
    KADOR, PF
    [J]. MEDICINAL RESEARCH REVIEWS, 1988, 8 (03) : 325 - 352
  • [39] A perspective of aldose reductase inhibitors and diabetic complications
    Dvornik, D
    [J]. CROATICA CHEMICA ACTA, 1996, 69 (02) : 613 - 630
  • [40] Genetic analysis of aldose reductase in diabetic complications
    Chung, SSM
    Chung, SK
    [J]. CURRENT MEDICINAL CHEMISTRY, 2003, 10 (15) : 1375 - 1387
12345